Tirzepatide represents a groundbreaking treatment agent for individuals battling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://dillanutfd771453.blogdeazar.com/40931825/tirzepatide-a-novel-glp-1-and-gip-receptor-agonist